Cerenome, Inc. CNSY
0.63 USD -0.07 (-10.29%)
Regular-session close
0.63 0.00 -0.02%
After hours · Nov 20, 4:24 PM ET
0.6301 Day range 0.7374
0.57 52-week range 18.00
- YTD
- -95.06%
- 1 year
- -94.86%
5D -0.0961 (-11.97%)
- Market cap
- 6.16M
- EPS (ttm)
- -3.50
- YTD return
- -95.06%
- 1-year return
- -94.86%
- Volume
- 256.65K
- Avg volume
- 801.83K
- Open
- 0.6951
- Previous close
- 0.7024
- Day's range
- 0.6301 – 0.7374
- 52-week range
- 0.57 – 18.00
Fundamental scorecard
6 of 25 checks passed on CNSY’s reported financials
6of 25 checks passed
- Value 1 of 5
- Growth 2 of 5
- Profitability 1 of 5
- Financial health 2 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
CNSY Revenue — quarterly 722.00K
CNSY Net income — quarterly -8.66M
CNSY EPS — quarterly -1.14
News
NVIDIA To $230? Here Are 10 Top Analyst Forecasts For Wednesday HC Wainwright & Co. Maintains Buy on Cerenome, Raises Price Target to $7
Cerenome, Inc. (CNSY) Q3 2026 Earnings Call Transcript Cerenome Announced Interim Data From Its Ongoing ReSPECT-LM Study Of Repeated Intraventricular Dosing Of REYOBIQ; No Dose-Limiting Toxicities Or Adverse Events Leading To Treatment Discontinuation Have Been Reported
Cerenome Reports Interim ReSPECT-LM Data Supporting Repeat Dosing of REYOBIQ™ in Leptomeningeal Metastases at the 2026 SNO Annual Meeting Cerenome Q3 EPS $(1.14) Misses $(0.95) Estimate, Sales $722.000K Miss $920.333K Estimate
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session CNSide Diagnostics Inks National In-Network Laboratory Ancillary Provider With Aetna Health Plans
12 Health Care Stocks Moving In Tuesday's Intraday Session
Your note
Sign in to keep a note on CNSY — it syncs with the Stock Master app.
